This is the slide. It is a commercial opportunity for Navidea to market in the "clinical/research" setting.
tilManocept has been determined to be safe to use, so Navidea will "initially" market/sale to companies performing FDA studies and clinical trials, so those companies can access the effectiveness of their study/trial products in days and weeks instead of in months and years, so Navidea is nor selling directly to doctors or hospitals like LS for patient administration, but selling to other companies/entities for their studies and trials.